Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SAXAGLIPTIN Cause Myocardial infarction? 75 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Myocardial infarction have been filed in association with SAXAGLIPTIN (SAXAGLIPTIN). This represents 3.0% of all adverse event reports for SAXAGLIPTIN.

75
Reports of Myocardial infarction with SAXAGLIPTIN
3.0%
of all SAXAGLIPTIN reports
6
Deaths
56
Hospitalizations

How Dangerous Is Myocardial infarction From SAXAGLIPTIN?

Of the 75 reports, 6 (8.0%) resulted in death, 56 (74.7%) required hospitalization, and 3 (4.0%) were considered life-threatening.

Is Myocardial infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SAXAGLIPTIN. However, 75 reports have been filed with the FAERS database.

What Other Side Effects Does SAXAGLIPTIN Cause?

Cardiac failure congestive (393) Cardiac failure (360) Cardiovascular disorder (159) Blood glucose increased (152) Weight decreased (124) Death (115) Nausea (113) Drug ineffective (105) Dizziness (91) Drug dose omission (89)

What Other Drugs Cause Myocardial infarction?

ROSIGLITAZONE (17,018) TESTOSTERONE (3,396) ADALIMUMAB (3,214) SACUBITRIL\VALSARTAN (3,120) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391) APIXABAN (2,010) TICAGRELOR (1,749) LENALIDOMIDE (1,712) ETANERCEPT (1,693) METFORMIN\ROSIGLITAZONE (1,640)

Which SAXAGLIPTIN Alternatives Have Lower Myocardial infarction Risk?

SAXAGLIPTIN vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER SAXAGLIPTIN vs SCOPOLAMINE SAXAGLIPTIN vs SCOPOLAMINE HYDROBROMIDE SAXAGLIPTIN vs SEBELIPASE ALFA SAXAGLIPTIN vs SECNIDAZOLE

Related Pages

SAXAGLIPTIN Full Profile All Myocardial infarction Reports All Drugs Causing Myocardial infarction SAXAGLIPTIN Demographics